Ongoing clinical trials in intracerebral hemorrhage

Stroke

Volumn 44, Issue SUPPL. 1, 2013, Pages

  Gonzales, Nicole R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Clinical trial; Intracerebral hemorrhage; Therapy

Indexed keywords

ALTEPLASE; ANTIHYPERTENSIVE AGENT; DEFEROXAMINE; HEMOSTATIC AGENT; PIOGLITAZONE; WARFARIN;

BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; CLINICAL TRIAL (TOPIC); CONFERENCE PAPER; DRUG MEGADOSE; DRUG SAFETY; GENETIC RISK; HEMATOMA; HUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR;

CLINICAL TRIAL; INTRACEREBRAL HEMORRHAGE; THERAPY;

CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; ENDOVASCULAR PROCEDURES; HUMANS; NEUROSURGICAL PROCEDURES; STROKE;

EID: 84880304117     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.000563     Document Type: Conference Paper

References (34)

1. Cheung RT. Update on medical and surgical management of intracerebral hemorrhage. Rev Recent Clin Trials. 2007;2:174-181.
2. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project-1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry. 1990;53:16-22.
3. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115:e69-e171.
4. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53-63.
5. Sangha N, Gonzales NR. Treatment targets in intracerebral hemorrhage. Neurotherapeutics. 2011;8:374-387.
6. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1-5.
7. Broderick JP, Brott TG, Tomsick T, Barsan W, Spilker J. Ultra-early evaluation of intracerebral hemorrhage. J Neurosurg. 1990;72:195-199.
8. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke. 1998;29:1160-1166.
9. Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061-2065.
10. Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Dávalos A; Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005;36:86-91.
11. Anderson CS, Huang Y, Wang JG, Arima H, Neal B, Peng B, et al INTERACT Investigators. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391-399.
12. Qureshi AI. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637-648
13. Anderson C. The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT2). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine 9US).Available at: http://clinicaltrials.gov/ct2/show/NCT00716079.
14. Qureshi AI. Antihypertensive Treatment in Acute Cerebral Hemorrhage-II (ATACH-II). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [2012 May 20]. Available at: http://clinicaltrials.gov/ ct2/show/NCT01176565.
15. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
16. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137.
17. Delgado Almandoz JE, Yoo AJ, Stone MJ, Schaefer PW, Goldstein JN, Rosand J, et al. Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke. 2009;40:2994-3000.
18. Demchuk AM, Dowlatshahi D, Rodriguez-Luna D, Molina CA, Blas YS, Dzialowski I, et al; PREDICT/Sunnybrook ICH CTA study group. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol. 2012;11:307-314.
19. Flaherty M, Jauch E. Spot sign for predicting and treating ICH growth study (stop-it).2011.
20. Gladstone DJ. "Spot Sign" Selection of Intracerebral Hemorrhage to Guide Hemostatic Therapy (SPOTLIGHT) [online]. In: ClinicalTrials. gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2012 Dec19]. Available at: http://clinicaltrials.gov/ct2/show/NCT01359202.
21. Morgenstern LB, Frankowski RF, Shedden P, Pasteur W, Grotta JC. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology. 1998;51:1359-1363.
22. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al; STICH investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397.
23. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology. 2001;56:1294-1299.
24. Mendelow AD. Surgical trial in lobar intracerebral hemorrhage [online]. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [ cited 2012 Dec 19].Available at: http://www.clinicaltrials.gov/ show/NCT01320423.
25. Dusick JR, Dye J, Gonzalez N, Varma J, Frazee J, Vespa PM, et al. Abstract 3022: Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage. Stroke. 2012;43:A3022
26. Hanley D. MIS+rtPA for ICH Evacuation. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2012 Dec 19] Available at: http://clinicaltrials.gov/ct2/show/NCT00224770.
27. Zhao X, Sun G, Zhang J, Strong R, Song W, Gonzales N, et al. Hematoma resolution as a target for intracerebral hemorrhage treatment: Role for peroxisome proliferator-activated receptor gamma in microglia/macrophages. Ann Neurol. 2007;61:352-362.
28. Gonzales NR, Shah J, Sangha N, Sosa L, Martinez R, Shen L, et al. Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). Int J Stroke. February 12, 2012. doi: 10.1111/j.1747-4949.2011.00761.x.
29. Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, et al; Deferoxamine Mesylate in Intracerebral Hemorrhage Investigators. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011;42:3067-3074.
30. Selim M. High-Dose Deferoxamine in Intracerebral Hemorrhage (HI-DEF) In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2012 Oct 29]. Available at: http://clinicaltrials.gov/ct2/show/ NCT01662895.
31. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011;42:3009-3016.
32. Mattle HP, Raabe A. CLEAR intraventricular hemorrhage: more than a glimmer of hope. Stroke. 2011;42:2999-3000.
33. Hanley D. Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR III) In: ClinicalTrials. gov [Internet]. Bethesda (MD): National Library of Medicine 9US). 2000 [2012 Oct 29] Available at: http://clinicaltrials.gov/ct2/show/NCT00784134.
34. Steiner T. International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage (INCH) In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 [cited 2012 Oct 31]. Available at: http://clinicaltrials.gov/ct2/show/NCT00928915.